In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro

(2016) Alejandro Ibáñez-Costa et al.   JOURNAL OF ENDOCRINOLOGY

Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis

(2014) John D. Carmichael et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

(2014) A. Colao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expert consensus document: A consensus on the medical treatment of acromegaly

(2014) Andrea Giustina et al.   Nature Reviews Endocrinology

Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies

(2013) Laura Chinezu et al.   HUMAN PATHOLOGY

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide

(2013) Olivera Casar-Borota et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

(2012) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Resistance to Somatostatin Analogs in Acromegaly

(2011) Annamaria Colao et al.   ENDOCRINE REVIEWS

Ligand-Dependent Mechanisms of sst2A Receptor Trafficking: Role of Site-Specific Phosphorylation and Receptor Activation in the Actions of Biased Somatostatin Agonists

(2011) Yachu J. Kao et al.   MOLECULAR ENDOCRINOLOGY

Reassessment of sst5 Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4

(2011) Amelie Lupp et al.   NEUROENDOCRINOLOGY

Medical Therapy of Acromegaly

(2009) Richard A. Feelders et al.   DRUGS

Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas

(2009) Christiaan de Bruin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways

(2009) Renzo Cescato et al.   MOLECULAR ENDOCRINOLOGY

Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas

(2008) Ursula Plöckinger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro

(2008) Sarah Lesche et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM